Standout Papers

Targeting the phosphoinositide 3-kinas... 1985 2026 1998 2012 2.1k
  1. Targeting the phosphoinositide 3-kinase pathway in cancer (2009)
    Pixu Liu, Hailing Cheng et al. Nature Reviews Drug Discovery
  2. CDK4/6 inhibition triggers anti-tumour immunity (2017)
    Shom Goel, Molly J. DeCristo et al. Nature
  3. ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK (1992)
    Kenneth W. Wood, Thomas M. Roberts et al. Cell
  4. Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation (1985)
    Malcolm Whitman, David R. Kaplan et al. Nature
  5. A histone H3 lysine 27 demethylase regulates animal posterior development (2007)
    Fei Lan, Peter Bayliss et al. Nature
  6. Activation of Mitogen-Activated Protein Kinase Kinase by v-Raf in NIH 3T3 Cells and in Vitro (1992)
    Paul Dent, W G Haser et al. Science
  7. Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity (1987)
    David R. Kaplan, Malcolm Whitman et al. Cell
  8. KRAS and YAP1 Converge to Regulate EMT and Tumor Survival (2014)
    Diane D. Shao, Wen Xue et al. Cell
  9. Essential roles of PI(3)K–p110β in cell growth, metabolism and tumorigenesis (2008)
    Shidong Jia, Zhenning Liu et al. Nature
  10. The X-Linked Mental Retardation Gene SMCX/JARID1C Defines a Family of Histone H3 Lysine 4 Demethylases (2007)
    Shigeki Iwase, Fei Lan et al. Cell
  11. An F876L Mutation in Androgen Receptor Confers Genetic and Phenotypic Resistance to MDV3100 (Enzalutamide) (2013)
    Manav Korpal, Joshua M. Korn et al. Cancer Discovery
  12. PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer (2018)
    Liya Ding, Hye‐Jung Kim et al. Cell Reports
  13. STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer (2022)
    Qiwei Wang, Johann S. Bergholz et al. Nature Communications

Immediate Impact

26 by Nobel laureates 81 from Science/Nature 161 standout
Sub-graph 1 of 15

Citing Papers

Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance
2017 StandoutNature
1 intermediate paper

Works of Thomas M. Roberts being referenced

The metabolic function of cyclin D3–CDK6 kinase in cancer cell survival
2017 Nature
CDK4/6 inhibition triggers anti-tumour immunity
2017 StandoutNature
and 2 more

Author Peers

Author Last Decade Papers Cites
Thomas M. Roberts 19460 7514 3322 3566 305 28.5k
Hartmut Beug 15981 7340 4181 2836 252 25.1k
George F. Vande Woude 17126 6259 3445 4026 243 27.5k
Michael D. Waterfield 20706 7159 3731 5171 187 32.1k
Mark C. Willingham 17440 9303 3746 4685 423 33.2k
Martine F. Roussel 19271 12304 2561 2906 241 27.6k
Alan D. D’Andrea 24904 11026 4935 2822 310 32.0k
Kevan M. Shokat 23898 6774 1256 5375 301 33.5k
Yue Xiong 23999 11215 2200 4986 253 33.7k
A. Ullrich 22416 8998 2599 3746 192 32.8k
Kristian Helin 30940 8998 4602 1946 272 36.5k

All Works

Loading papers...

Rankless by CCL
2026